Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery.
Sign Up to like & getrecommendations! Published in 2022 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.1c00996
Abstract: Glioblastoma (GB) is recognized as the most aggressive form of primary brain cancer. Despite advances in treatment strategies that include surgery, radiation, and chemotherapy, the median survival time (∼15 months) of patients with GB has… read more here.
Keywords: target glioblastoma; glioblastoma overcoming; antibody based; based formats ... See more keywords
Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23031711
Abstract: Glioblastoma multiforme is the most lethal intrinsic brain tumor. Even with the existing treatment regimen of surgery, radiation, and chemotherapy, the median survival time is only 15–23 months. The invasive nature of this tumor makes… read more here.
Keywords: overcoming biological; therapeutics glioblastoma; glioblastoma overcoming; delivering therapeutics ... See more keywords